Compound information
- Natural Products
- ZC1729908
- Molecular Formula
- C17H17NO4
- Molecular Weight
- 299.115758024 g/mol
- Structure
-
- IUPAC Name
- 4-[(1R)-1-(benzyloxycarbonylamino)ethyl]benzoic acid
- InChI
- InChI=1S/C17H17NO4/c1-12(14-7-9-15(10-8-14)16(19)20)18-17(21)22-11-13-5-3-2-4-6-13/h2-10,12H,11H2,1H3,(H,18,21)(H,19,20)/t12-/m1/s1
- InChI Key
- XZHNWUGYLBANCU-GFCCVEGCSA-N
- SMILES
- C[C@@H](NC(=O)OCc1ccccc1)c1ccc(C(=O)O)cc1
- Source
- ZINC000095080276
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 3.154 |
LogS | -3.455 | LogD | 2.663 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.003 | Pgp substrate | 0.029 |
HIA | 0.965 | F20 % | 0.995 |
F30 % | 0.904 | Caco-2 | -4.876 |
MDCK | -5.192 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.33 | PPB | 91.383 |
VD | 0.261 | Fu | 1.269 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.211 | CYP1A2 substrate | 0.746 |
CYP2A6 substrate | 0.647 | CYP2B6 substrate | 0.647 |
CYP2C19 inhibitor | 0.055 | CYP2C19 substrate | 0.81 |
CYP2C8 substrate | 0.791 | CYP2C9 inhibitor | 0.289 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.056 |
CYP2D6 substrate | 0.806 | CYP2E1 substrate | 0.342 |
CYP3A4 inhibitor | 0.061 | CYP3A4 substrate | 0.986 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.868 | CL | 0.977 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.004 | Hepatotoxicity | 0.558 |
Mutagenicity | 0.006 | Rat Oral Acute Toxicity | 0.056 |
FDAMDD | 0.051 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.03 | Eye Corrosion | 0.002 |
Eye Irritation | 0.016 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.288 | IGC50 | 2.449 |
LC50FM | 3.69 | LC50DM | 4.493 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.232 | NR-AR-LBD | 0.222 |
NR-AhR | 0.008 | NR-Aromatase | 0.034 |
NR-ER | 0.236 | NR-ER-LBD | 0.284 |
NR-PPAR-gamma | 0.451 | SR-ARE | 0.036 |
SR-ATAD5 | 0.336 | SR-HSE | 0.1 |
SR-MMP | 0.009 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.